Pacifico Biolabs Closes €7M Series A to Scale Mycelium Protein Through Idle German Brewery Infrastructure
Mycelium fermentation company Pacifico Biolabs has closed a €7 million Series A round to scale production to 200 tonnes per month and begin commercial launches across the DACH region and the Nordics. The round was backed by Stray Dog Capital, Technologiegründerfonds Sachsen (TGFS), Sprout & About Ventures, Simon Capital, FoodLabs, and a regional brewery partner. Repurposing idle brewing capacity The core of Pacifico’s production model involves running its fermentation process …

